Current Management of Pediatric Vitiligo

Area of Science:

• Dermatology
• Pediatrics
• Psychology

Background:

• Vitiligo affects 0.4-2% globally, with half of cases starting in childhood.
• Childhood vitiligo management must consider growth and psychological development.
• Therapy selection depends on lesion characteristics and the child's developmental stage.

Purpose of the Study:

• To review pediatric vitiligo therapeutics.
• To analyze treatment strategies based on developmental stages.
• To highlight psychological considerations in childhood vitiligo management.

Main Methods:

• Categorization of childhood vitiligo into four age groups (0-3, 4-8, 9-12, 13+ years).
• Assessment of psychological factors like bullying and self-image.
• Review of medical interventions including topical therapies, vitamin therapy, and phototherapy.
• Consideration of co-morbidities and cosmetic interventions.

Main Results:

• Therapeutic approaches vary significantly across developmental stages.
• Facial and leg lesions warrant intervention due to cosmetic concerns.
• Topical corticosteroids, calcineurin inhibitors, vitamin D, and phototherapy are primary medical treatments.
• Screening for co-morbidities and use of camouflage improve outcomes.

Conclusions:

• Tailored therapeutic strategies are crucial for effective pediatric vitiligo management.
• Developmental stage and psychological impact must guide treatment decisions.
• A multidisciplinary approach enhances overall patient well-being and quality of life.